Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses

Molecular Immunology

Volumn 48, Issue 6-7, 2011, Pages 835-845

  Verweij, Marieke C ^a   Ressing, Maaike E ^a,b   Knetsch, Wilco ^a   Quinten, Edwin ^a   Halenius, Anne ^c   van Bel, Nikki ^a   Hengel, Hartmut ^c   Drijfhout, Jan Wouter ^a   van Hall, Thorbald ^a,b   Wiertz, Emmanuel J H J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antigen presentation; Herpesviruses; Immune evasion; MHC class I; Mouse model

Indexed keywords

BOVINE HERPES VIRUS 1 PROTEIN UL 49 5; CYSTEINE; EPSTEIN BARR VIRUS PROTEIN BNLF 2A; GAMMA INTERFERON; HERPES SIMPLEX VIRUS PROTEIN ICP 47; HUMAN CYTOMEGALOVIRUS PROTEIN US 3; HUMAN CYTOMEGALOVIRUS PROTEIN US 6 DERIVATIVE; IMMUNOMODULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEIN INHIBITOR; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; ABC TRANSPORTER; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; PEPTIDE; TAP1 PROTEIN, MOUSE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; CROSS PRESENTATION; DOWN REGULATION; DRUG MECHANISM; DRUG SYNTHESIS; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HAPLOTYPE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CATTLE; CELL STRAIN 3T3; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENDOPLASMIC RETICULUM; GENETICS; HELA CELL; HERPES VIRUS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

BOVINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; MURINAE; SIMPLEXVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CATTLE; CYSTEINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; HAPLOTYPES; HELA CELLS; HERPESVIRIDAE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; INTERFERON-GAMMA; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY; VIRAL PROTEINS;

EID: 79953324778     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.12.008     Document Type: Article

References (65)

1. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12889-12894.
2. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 2005, 6:107-113.
3. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997, 6:613-621.
4. Ahn K., Meyer T.H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P.A., Fruh K., Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996, 15:3247-3255.
5. Aisenbrey C., Sizun C., Koch J., Herget M., Abele R., Bechinger B., Tampe R. Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery. J. Biol. Chem. 2006, 281:30365-30372.
6. Alzhanova D., Edwards D.M., Hammarlund E., Scholz I.G., Horst D., Wagner M.J., Upton C., Wiertz E.J., Slifka M.K., Fruh K. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host. Microbe 2009, 6:433-445.
7. Banks T.A., Jenkins F.J., Kanangat S., Nair S., Dasgupta S., Foster C.M., Rouse B.T. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology 1994, 200:236-245.
8. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978, 14:9-20.
9. Burgdorf S., Scholz C., Kautz A., Tampe R., Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 2008, 9:558-566.
10. Byun M., Verweij M.C., Pickup D.J., Wiertz E.J., Hansen T.H., Yokoyama W.M. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host. Microbe 2009, 6:422-432.
11. Cadwell K., Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005, 309:127-130.
12. Cadwell K., Coscoy L. The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J. Virol. 2008, 82:4184-4189.
13. Coscoy L., Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8051-8056.
14. Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., Wearsch P.A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 2005, 207:145-157.
15. de la Garza-Rodea A.S., Verweij M.C., Boersma H., van der Velde-van Dijke I., de Vries A.A.F., Hoeben R.C., van Bekkum D.W., Wiertz E.J.H.J., Knaan-Shanzer S. Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants. PLoS ONE 2011, 6:e14493.
16. Dugan G.E., Hewitt E.W. Structural and functional dissection of the human cytomegalovirus immune evasion protein US6. J. Virol. 2008, 82:3271-3282.
17. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P.M., Tampe R., Peterson P.A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375:415-418.
18. Furman M.H., Loureiro J., Ploegh H.L., Tortorella D. Ubiquitinylation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the endoplasmic reticulum. J. Biol. Chem. 2003, 278:34804-34811.
19. Furman M.H., Ploegh H.L., Tortorella D. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J. Biol. Chem. 2002, 277:3258-3267.
20. Grandea A.G., Golovina T.N., Hamilton S.E., Sriram V., Spies T., Brutkiewicz R.R., Harty J.T., Eisenlohr L.C., Van K.L. Impaired assembly yet normal trafficking of MHC class I molecules in tapasin mutant mice. Immunity 2000, 13:213-222.
21. Griffin B.D., Verweij M.C., Wiertz E.J. Herpesviruses and immunity: the art of evasion. Vet. Microbiol. 2010, 143:89-100.
22. Halenius A., Momburg F., Reinhard H., Bauer D., Lobigs M., Hengel H. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J. Biol. Chem. 2006, 281:5383-5390.
23. Hansen T.H., Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 2009, 9:503-513.
24. Hengel H., Koopmann J.O., Flohr T., Muranyi W., Goulmy E., Hammerling G.J., Koszinowski U.H., Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 1997, 6:623-632.
25. Hewitt E.W., Gupta S.S., Lehner P.J. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 2001, 20:387-396.
26. Hiemstra H.S., Duinkerken G., Benckhuijsen W.E., Amons R., de Vries R.R., Roep B.O., Drijfhout J.W. The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10313-10318.
27. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415.
28. Hislop A.D., Ressing M.E., van Leeuwen D., Pudney V.A., Horst D., Koppers-Lalic D., Croft N.P., Neefjes J.J., Rickinson A.B., Wiertz E.J. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 2007, 204:1863-1873.
29. Horst D., van Leeuwen D., Croft N.P., Garstka M.A., Hislop A.D., Kremmer E., Rickinson A.B., Wiertz E.J., Ressing M.E. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J. Immunol. 2009, 182:2313-2324.
30. Horst D., Verweij M.C., Davison A.J., Ressing M.E., Wiertz E.J. Viral evasion of T cell immunity: ancient mechanism offering new applications. Curr. Opin. Immunol. 2011.
31. Ishido S., Wang C., Lee B.S., Cohen G.B., Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 2000, 74:5300-5309.
32. Jones T.R., Wiertz E.J., Sun L., Fish K.N., Nelson J.A., Ploegh H.L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11327-11333.
33. Khan S., Bijker M.S., Weterings J.J., Tanke H.J., Adema G.J., van Hall T., Drijfhout J.W., Melief C.J., Overkleeft H.S., van der Marel G.A., Filippov D.V., van der Burg S.H., Ossendorp F. Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J. Biol. Chem. 2007, 282:21145-21159.
34. Khong H.T., Restifo N.P. Natural selection of tumor variants in the generation of " tumor escape" phenotypes. Nat. Immunol. 2002, 3:999-1005.
35. Koopmann J.O., Post M., Neefjes J.J., Hammerling G.J., Momburg F. Translocation of long peptides by transporters associated with antigen processing (TAP). Eur. J. Immunol. 1996, 26:1720-1728.
36. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., Marcondes R.M., Admiraal P., van Leeuwen D., Bienkowska-Szewczyk K., Mettenleiter T.C., Rijsewijk F.A., Tampe R., Neefjes J., Wiertz E.J. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5144-5149.
37. Kyritsis C., Gorbulev S., Hutschenreiter S., Pawlitschko K., Abele R., Tampe R. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 2001, 276:48031-48039.
38. Lee S., Yoon J., Park B., Jun Y., Jin M., Sung H.C., Kim I.H., Kang S., Choi E.J., Ahn B.Y., Ahn K. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J. Virol. 2000, 74:11262-11269.
39. Lehner P.J., Karttunen J.T., Wilkinson G.W., Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6904-6909.
40. Lehner P.J., Trowsdale J. Antigen presentation: coming out gracefully. Curr. Biol. 1998, 8:R605-R608.
41. Lilley B.N., Ploegh H.L. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 2005, 207:126-144.
42. Lipinska A.D., Koppers-Lalic D., Rychlowski M., Admiraal P., Rijsewijk F.A., Bienkowska-Szewczyk K., Wiertz E.J. Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J. Virol. 2006, 80:5822-5832.
43. Luckey C.J., Marto J.A., Partridge M., Hall E., White F.M., Lippolis J.D., Shabanowitz J., Hunt D.F., Engelhard V.H. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 2001, 167:1212-1221.
44. Lybarger L., Wang X., Harris M., Hansen T.H. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr. Opin. Immunol. 2005, 17:71-78.
45. Lybarger L., Wang X., Harris M.R., Virgin H.W., Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity 2003, 18:121-130.
46. Marincola F.M., Jaffee E.M., Hicklin D.J., Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 2000, 74:181-273.
47. Momburg F., Roelse J., Hammerling G.J., Neefjes J.J. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 1994, 179:1613-1623.
48. Myers N.B., Harris M.R., Connolly J.M., Lybarger L., Yu Y.Y., Hansen T.H. Kb, Kd, and Ld molecules share common tapasin dependencies as determined using a novel epitope tag. J. Immunol. 2000, 165:5656-5663.
49. Pande N.T., Powers C., Ahn K., Fruh K. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J. Virol. 2005, 79:5786-5798.
50. Park B., Kim Y., Shin J., Lee S., Cho K., Fruh K., Lee S., Ahn K. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 2004, 20:71-85.
51. Peaper D.R., Cresswell P. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 2008, 24:343-368.
52. Prasanna S.J., Nandi D. The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression: roles of TAP, Tapasin and beta2-microglobulin. Mol. Immunol. 2004, 41:1029-1045.
53. Rizvi S.M., Raghavan M. Mechanisms of Function of Tapasin, a Critical Major Histocompatibility Complex Class I Assembly Factor. Traffic 2009, 11:332-347.
54. Schuurhuis D.H., Ioan-Facsinay A., Nagelkerken B., van Schip J.J., Sedlik C., Melief C.J., Verbeek J.S., Ossendorp F. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 2002, 168:2240-2246.
55. Stevenson P.G., Efstathiou S., Doherty P.C., Lehner P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8455-8460.
56. Tomazin R., Hill A.B., Jugovic P., York I., van Endert P., Ploegh H.L., Andrews D.W., Johnson D.C. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 1996, 15:3256-3266.
57. Turnquist H.R., Vargas S.E., Reber A.J., McIlhaney M.M., Li S., Wang P., Sanderson S.D., Gubler B., van Endert P., Solheim J.C. A region of tapasin that affects L(d) binding and assembly. J. Immunol. 2001, 167:4443-4449.
58. van Hall T., Laban S., Koppers-Lalic D., Koch J., Precup C., Asmawidjaja P., Offringa R., Wiertz E.J. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1. J. Immunol. 2007, 178:657-662.
59. van Hall T., Wolpert E.Z., van Veelen P., Laban S., van der Veer V., Roseboom M., Bres S., Grufman P., de Ru A., Meiring H., de Jong A., Franken K., Teixeira A., Valentijn R., Drijfhout J.W., Koning F., Camps M., Ossendorp F., Karre K., Ljunggren H.G., Melief C.J., Offringa R. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat. Med. 2006, 12:417-424.
60. van Montfoort N., Camps M.G., Khan S., Filippov D.V., Weterings J.J., Griffith J.M., Geuze H.J., van Hall T., Verbeek J.S., Melief C.J., Ossendorp F. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6730-6735.
61. Verweij M.C., Koppers-Lalic D., Loch S., Klauschies F., de la Salle H., Quinten E., Lehner P.J., Mulder A., Knittler M.R., Tampe R., Koch J., Ressing M.E., Wiertz E.J. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J. Immunol. 2008, 181:4894-4907.
62. Wang X., Lybarger L., Connors R., Harris M.R., Hansen T.H. Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex 11. J. Virol. 2004, 78:8673-8686.
63. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996, 84:769-779.
64. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
65. Wright C.A., Kozik P., Zacharias M., Springer S. Tapasin and other chaperones: models of the MHC class I loading complex. Biol. Chem. 2004, 385:763-778.